Survival and Prognostic Analysis after Pulmonary Metastasectomy for Head and Neck Cancer
Conclusion Despite the lack of randomized controlled trials, PM for HNC is a reasonable therapeutic option with favorable survival in a selected population. In patients with larger pulmonary lesions, shorter OS after PM is to be expected. [...] Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Dudek, Wojciech AlMoussa, Emad Schreiner, Waldemar Mantsopoulos, Konstantinos Sirbu, Horia Tags: Original Thoracic Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Head and Neck Cancer | Heart | Study